Learn languages naturally with fresh, real content!

Popular Topics
Explore By Region
A Johns Hopkins study shows psilocybin, with therapy, helped 41% quit smoking long-term—six times better than nicotine patches—sparking hope for new addiction treatments.
A Johns Hopkins University study finds that a single dose of psilocybin significantly increases smoking cessation success, with 17 out of 41 participants remaining smoke-free after six months—more than six times the rate of those using nicotine patches.
All 82 participants received 13 weeks of cognitive behavioral therapy, but no placebo was used due to psilocybin’s distinct effects.
Researchers attribute the results to both the drug’s potential to alter brain connectivity and promote neuroplasticity, and the intensive therapeutic support during sessions.
The findings, part of a growing effort to explore psychedelics for addiction, offer a novel non-nicotine approach, especially as no new smoking cessation medications have been approved in two decades.
Larger trials with placebo controls are underway.
Un estudio de Johns Hopkins muestra que la psilocibina, junto con la terapia, ayudó al 41% a dejar de fumar a largo plazo, seis veces mejor que los parches de nicotina, lo que despierta esperanzas de nuevos tratamientos para la adicción.